SEARCH

SEARCH BY CITATION

References

  • Addya K., Wang Y. L. and Leonard D. G. (1997) Optimization of apolipoprotein E genotyping. Mol. Diagn. 2, 271276.
  • Ames B. N., Shigenaga M. K. and Hagen T. M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl Acad. Sci. USA 90, 79157922.
  • Arnaiz E., Jelic V., Almkvist O., Wahlund L. O., Winblad B., Valind S. and Nordberg A. (2001) Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. NeuroReport 12, 851855.
  • Beckett T. L., Niedowicz D. M., Studzinski C. M., Weidner A. M., Webb R. L., Holler C. J., Ahmed R. R., LeVine H. III and Murphy M. P. (2010) Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle. Neurobiol. Dis. 39, 449456.
  • Braak H., Braak E., Bohl J. and Lang W. (1989) Alzheimer's disease: amyloid plaques in the cerebellum. J. Neurol. Sci. 93, 277287.
  • Bradley M. A., Markesbery W. R. and Lovell M. A. (2010) Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biol. Med. 48, 15701576.
  • Bradley M. A., Xiong-Fister S., Markesbery W. R. and Lovell M. A. (2012) Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiol. Aging 33, 10.
  • Cadet J., Douki T., Gasparutto D. and Ravanat J. L. (2003) Oxidative damage to DNA: formation, measurement and biochemical features. Mutat. Res. 531, 523.
  • Cairns N. J., Bigio E. H., Mackenzie I. R. et al. (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 522.
  • Collins A., Cadet J., Epe B. and Gedik C. (1997) Problems in the measurement of 8-oxoguanine in human DNA. Report of a workshop, DNA oxidation, held in Aberdeen, UK, 19-21 January, 1997. Carcinogenesis 18, 18331836.
  • Cooke M. S., Evans M. D., Dizdaroglu M. and Lunec J. (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17, 11951214.
  • Cullis P. M., Malone M. E. and Merson-Davies L. A. (1996) Guanine radical cations are precusors of 7,8-dihydro-8-oxo-2'-deoxyguanosine but are not precusors of immediate strand breaks in DNA. J. Am. Chem. Soc. 118, 6.
  • Cysewski P. and Olinski R. (1999) Theoretical description of the coding potential of diamino-5-formamidopyrimidines. Z. Naturforsch. C. 54, 6.
  • Das P., Howard V., Loosbrock N., Dickson D., Murphy M. P. and Golde T. E. (2003) Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice. J. Neurosci. 23, 85328538.
  • Devasagayam T. P. A., Steeken S., Maik S., Obendorf W., Schulz W. A. and Sies H. (1991) Formation of 8-hdyroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen. J. Am. Chem. Soc. 30, 7.
  • Dizdaroglu M. and Gajewski E. (1990) Selected-ion mass spectrometry: assays of oxidative DNA damage. Methods Enzymol. 186, 530544.
  • Drzezga A., Lautenschlager N., Siebner H., Riemenschneider M., Willoch F., Minoshima S., Schwaiger M. and Kurz A. (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur. J. Nucl. Med. Mol. Imaging 30, 11041113.
  • Du Y., Wooten M. C., Gearing M. and Wooten M. W. (2009a) Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radical Biol. Med. 46, 492501.
  • Du Y., Wooten M. C. and Wooten M. W. (2009b) Oxidative damage to the promoter region of SQSTM/p62 is common to neurodegenerative disease. Neurobiol. Dis. 35, 9.
  • Dzitoyeva S., Chen H. and Manev H. (2012) Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiol. Aging 33, 28812891.
  • Ernster L. and Schatz G. (1981) Mitochondria: a historical review. J. Cell Biol. 91, 227s255s.
  • Fukuyama H., Ogawa M., Yamauchi H., Yamaguchi S., Kimura J., Yonekura Y. and Konishi J. (1994) Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J. Nucl. Med. 35, 16.
  • Gabbita S. P., Lovell M. A. and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71, 20342040.
  • Gabbita S. P., Aksenov M. Y., Lovell M. A. and Markesbery W. R. (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73, 16601666.
  • Hailer-Morrison M. K., Kotler J. M., Martin B. D. and Sugden K. D. (2003) Oxidized guanine lesions as modulators of gene transcription. Altered p50 binding affinity and repair shielding by 7,8-dihydro-8-oxo-2'deoxyguanosine lesions in the NF-kappaB promoter element. Biochemistry 42, 10.
  • Halliwell B. and Dizdaroglu M. (1992) The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 16, 7587.
  • Harman D. (1956) Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298300.
  • Hayashi S., Toyoshima Y., Hasegawa M., Umeda Y., Wakabayashi K., Tokiguchi S., Iwatsubo T. and Takahashi H. (2002) Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol. 51, 525530.
  • Hutter M. and Clark T. (1996) On the enhanced stability of the guanine-cytosine pair radical cation. J. Am. Chem. Soc. 118, 4.
  • Hyman B. T., Phelps C. H., Beach T. G. et al. (2012) National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8, 113.
  • Iida T., Furuta A., Nishioka K., Nakabeppu Y. and Iwaki T. (2002) Expression of 8-oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer's disease brain. Acta Neuropathol. 103, 2025.
  • Imam S. Z., Karahalil B., Hogue B. A., Souza-Pinto N. C. and Bohr V. A. (2006) Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol. Aging 27, 11291136.
  • Ishii K., Imamura T., Sasaki M., Yamaji S., Sakamoto S., Kitagaki H., Hashimoto M., Hirono N., Shimomura T. and Mori E. (1998a) Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 51, 125130.
  • Ishii K., Sakamoto S., Sasaki M., Kitagaki H., Yamaji S., Hashimoto M., Imamura T., Shimomura T., Hirono N. and Mori E. (1998b) Cerebral glucose metabolism in patients with frontotemporal dementia. J. Nucl. Med. 39, 18751878.
  • Jenner A., England T. G., Aruoma O. I. and Halliwell B. (1998) Measurement of oxidative DNA damage by gas chromatography-mass spectrometry: ethanethiol prevents artifactual generation of oxidized DNA bases. Biochem. J. 331, 365369.
  • LeVine H., 3rd (2004) Alzheimer's beta-peptide oligomer formation at physiologic concentrations. Anal. Biochem. 335, 8190.
  • Levites Y., Das P., Price R. W., Rochette M. J., Kostura L. A., McGowan E. M., Murphy M. P. and Golde T. E. (2006) Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J. Clin. Investig. 116, 193201.
  • Lovell M. A., Gabbita S. P. and Markesbery W. R. (1999) Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72, 771776.
  • Lovell M. A., Xiong S., Lyubartseva G. and Markesbery W. R. (2009) Organo-selenium (sel-plex) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radical Biol. Med. 46, 7.
  • Lovell M. A., Soman S. and Bradley M. A. (2011) Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech. Ageing Dev. 132, 443448.
  • Lu T., Pan Y., Kao S. Y., Li C., Kohane I., Chan J. and Yankner B. A. (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429, 883891.
  • Lyras L., Cairns N. J., Jenner A., Jenner P. and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 20612069.
  • Mao G., Pan X., Zhu B. B. et al. (2007) Identification and characterization of OGG1 mutations in patients with Alzheimer's disease. Nucleic Acids Res. 35, 27592766.
  • Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 23, 134147.
  • McKeith I. G., Galasko D., Kosaka K. et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 11131124.
  • McKeith I. G., Dickson D. W., Lowe J. et al. (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 18631872.
  • Mecocci P., MacGarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. C. and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brian. Ann. Neurol. 34, 609616.
  • Mecocci P., MacGarvey U. and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747751.
  • Mello Filho A. C. and Meneghini R. (1984) In vivo formation of single-strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim. Biophys. Acta 781, 5663.
  • de la Monte S. M., Luong T., Neely T. R., Robinson D. and Wands J. R. (2000) Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab. Invest. 80, 13231335.
  • Montine T. J., Phelps C. H., Beach T. G. et al. (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 123, 111.
  • Moreira P. I., Honda K., Liu Q., Santos M. S., Oliveira C. R., Aliev G., Nunomura A., Zhu X., Smith M. A. and Perry G. (2005) Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr. Alzheimer Res. 2, 403408.
  • Mori F., Piao Y. S., Hayashi S., Fujiwara H., Hasegawa M., Yoshimoto M., Iwatsubo T., Takahashi H. and Wakabayashi K. (2003) Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J. Neuropathol. Exp. Neurol. 62, 812819.
  • Murphy M. P., Beckett T. L., Ding Q., Patel E., Markesbery W. R., St Clair D. K., LeVine H. III and Keller J. N. (2007) A-beta solubility and deposition during AD progression and in APP x PS-1 knock-in mice. Neruobiol. Dis. 27, 301311.
  • Nakabeppu Y., Tsuchimoto D., Ichinoe A., Ohno M., Ide Y., Hirano S., Yoshimura D., Tominaga Y., Furuichi M. and Sakumi K. (2004) Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei. Ann. N. Y. Acad. Sci. 1011, 101111.
  • Neary D., Snowden J. S., Gustafson L. et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51, 15461554.
  • Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S. and Smith M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19, 19591964.
  • Nunomura A., Perry G., Pappolla M. A., Friedland R. P., Hirai K., Chiba S. and Smith M. A. (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59, 10111017.
  • Nunomura A., Perry G., Aliev G. et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759767.
  • Nunomura A., Tamaoki T., Tanaka K. et al. (2010) Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiol. Dis. 37, 731737.
  • Nunomura A., Tamaoki T., Motohashi N., Nakamura M., McKeel D. W. Jr, Tabaton M., Lee H. G., Smith M. A., Perry G. and Zhu X. (2012) The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J. Neuropathol. Exp. Neurol. 71, 233241.
  • Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G. and Kokmen E. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303308.
  • Prat F., Houk K. N. and Foote C. S. (1998) Effect of guanine stacking on the oxidation of 8-oxoguanine in B-DNA. J. Am. Chem. Soc. 120, 845846.
  • Rehman A., Jenner A. and Halliwell B. (2000) Gas chromatography-mass spectrometry ananlysis of DNA: optimization of protocols for isolation and analysis of DNA from human blood. Methods Enzymol. 319, 401416.
  • Schmitt F. A., Davis D. G., Wekstein D. R., Smith C. D., Ashford J. W. and Markesbery W. R. (2000) “Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology 55, 370376.
  • Schmitt F. A., Nelson P. T., Abner E. et al. (2012) University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr. Alzheimer Res. 9, 724733.
  • Shankar G. M., Li S., Mehta T. H. et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837842.
  • Shao C., Xiong S., Li G. M., Gu L., Mao G., Markesbery W. R. and Lovell M. A. (2008) Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radical Biol. Med. 45, 813819.
  • Smith M. A., Rottkamp C. A., Nunomura A., Raina A. K. and Perry G. (2000) Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502, 139144.
  • Szczesny B., Bhakat K. K., Mitra S. and Boldogh I. (2004) Age-dependent modulation of DNA repair enzymes by covalent modification and subcellular distribution. Mech. Ageing Dev. 125, 755765.
  • Thomann P. A., Schlafer C., Seidl U., Santos V. D., Essig M. and Schroder J. (2008) The cerebellum in mild cognitive impairment and Alzheimer's disease - a structural MRI study. J. Psychiatr. Res. 42, 11981202.
  • Timmons M. D., Bradley M. A., Lovell M. A. and Lynn B. C. (2011) Procedure for the isolation of mitochondria, cytosolic and nuclear material from a single piece of neurological tissue for high-throughput mass spectral analysis. J. Neurosci. Methods 197, 279282.
  • Tsukamoto K., Watanabe T., Matsushima T., Kinoshita M., Kato H., Hashimoto Y., Kurokawa K. and Teramoto T. (1993) Determination by PCR-RFLP of apo E genotype in a Japanese population. J. Lab. Clin. Med. 121, 598602.
  • Valinluck V., Tsai H. H., Rogstad D. K., Burdzy A., Bird A. and Sowers L. C. (2004) Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32, 41004108.
  • Wallace D. C. (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256, 628632.
  • Wang J., Xiong S., Xie C., Markesbery W. R. and Lovell M. A. (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 93, 953962.
  • Wang J., Markesbery W. R. and Lovell M. A. (2006) Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J. Neurochem. 96, 825832.
  • Wegiel J., Wisniewski H. M., Dziewiathkowski J., Badmajew E., Tarnawski M., Reisberg B., Mlodzik B., De Leon M. J. and Miller D. C. (1999) Cellbellar atropy in Alzheimer's disease - clinicopathological correlations. Brain Res. 818, 4150.
  • Weidner A. M., Bradley M. A., Beckett T. L., Niedowicz D. M., Dowling A. L., Matveev S. V., LeVine H. III, Lovell M. A. and Murphy M. P. (2011) RNA oxidation adducts 8-OHG and 8-OHA change with Abeta42 levels in late-stage Alzheimer's disease. PLoS ONE 6, e24930.
  • Weissman L., Jo D. G., Sorensen M. M., de Souza-Pinto N. C., Markesbery W. R., Mattson M. P. and Bohr V. A. (2007) Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res. 35, 55455555.
  • Weitzman S. A., Turk P. W., Milkowski D. H. and Kozlowski K. (1994) Free radical adducts induce alterations in DNA cytosine methylation. Proc. Natl Acad. Sci. USA 91, 12611264.
  • Yaari R. and Corey-Bloom J. (2007) Alzheimer's disease. Semin. Neurol. 27, 3241.
  • Yamaguchi H., Hirai S., Morimatsu M., Shoji M. and Nakazato Y. (1989) Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol. 77, 314319.